SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Inspiration Biopharmaceuticals Highlights Positive Interim Data on Its Two Lead Investigational Product Candidates: Recombinant Porcine FVIII (OBI-1) and Recombinant Factor IX (IB1001)